• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Mackenzie's Mission HomepageMackenzie's Mission

DONATE Mackenzies Mission Donate
  • Mission
  • About
    • The Story
    • Board
  • Resources
    • Resource List
    • What Is Amyloidosis
  • Speakers Bureau
    • About ASB
    • ASB Operating Committee
  • Fundraisers
  • Blog
  • Contact

#Andromeda

1st FDA-Approved Drug for AL Amyloidosis

January 16, 2021

After decades of relying on treatments approved for other diseases, on January 15, 2021 the FDA approved the first drug for AL Amyloidosis. Truly a game-changing, monumental advancement in the treatment of this disease.

Filed Under: Featured News, What Is Amyloidosis Tagged With: #Andromeda, AL amyloidosis, amyloidosis, amyloidosis clinical trials, amyloidosis news, amyloidosis treatment

Primary Sidebar

Recent News

  • FACES of Amyloidosis 2023
  • Hereditary Amyloidosis: The T60A Variant
  • Worldwide Hotspots of Hereditary ATTR Amyloidosis (ATTRv)
  • 2022: Mackenzie’s Mission – Our Report Card
  • CRISPR/Cas9 – ATTR Clinical Trial Update

Be A Part Of Our Mission!

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

  • Mission
  • About
  • Resources
  • Speakers Bureau
  • Fundraisers
  • Blog
  • Contact

Registered 501(c)(3) · Contact · Copyright © 2023 · Mackenzies Mission - All Rights Reserved